OrbitonOpen research workspace →

Apotex Health Corp.

TSX:APTXLive AI agent

Apotex is a Canadian-based pharmaceutical company focused on improving access to affordable, innovative medicines and health products for patients and consumers worldwide.

Investor website: https://apotex.com/

About

Apotex is a Canadian-based pharmaceutical company focused on improving access to affordable, innovative medicines and health products for patients and consumers worldwide. Since its founding, the company has prioritized making high-quality medicines accessible, serving as a trusted supplier of cost-effective, FDA-approved medicines across multiple therapeutic areas. Apotex is committed to quality, innovation, and health outcomes, aiming to reduce barriers to treatment and support sustainable care delivery.

Verified company data

Shares outstanding
231726671
Fully diluted shares
247662946
Leadership
Jeff Watson (President & CEO, Jeff Watson is the President and CEO of Apotex, leading a team of over 6,000 employees and guiding the strategic direction of the company.), Ariel Alon (Chief Operations Officer), Barry Fishman (Chief Corporate Development Officer, Barry Fishman is the Chief Corporate Development Officer of Apotex.), Brian McClelland (Chief Financial Officer, Brian McClelland oversees global financial functions and services.), Carina Vassilieva (Chief Human Resources Officer, Carina Vassilieva is the Chief Human Resources Officer of Apotex.), Christine Baeder (President, Apotex USA and LATAM, Christine Baeder is the President of Apotex for the USA and LATAM.), Francesco Tallarico (Chief Legal Officer and Global Head of Government Relations, Francesco Tallarico leads global legal affairs, compliance, government relations, and communications.), Kiran Krishnan (Senior Vice President, Global Regulatory Affairs, Dr. Kiran Krishnan is the Senior Vice President of Global Regulatory Affairs and Medical at Apotex.), Martin Arès (President, Apotex Canada and Rest of World (ROW), Martin Arès is the President of Apotex Canada and Rest of World.), Pradeep Sanghvi (Executive Vice President, Global Research and Development, Pradeep Sanghvi is the Executive Vice President of Global Research and Development at Apotex.)

Verified data last updated:

Recent filings